By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Phico Therapeutics 

Babraham Research Campus

Babraham  Cambridge  CB22 3AT  United Kingdom
Phone: 44-0-1223-496562 Fax: 44-0-1223-496018



Start Up

Company News
Phico Therapeutics Appoints Dr. Nicki Thompson As Chief Business Officer 1/26/2016 9:34:50 AM
Phico Therapeutics Receives Translation Award To Advance Its SASPject PT4 Aimed At Escherichia Coli And Klebsiella Pneumoniae Towards Clinical Trials 3/9/2015 10:30:28 AM
Phico Therapeutics Awarded Technology Strategy Board Biomedical Catalyst Grant To Develop Its SASPject Antibiotic Technology For Drug Resistant Bacteria 7/7/2014 1:06:25 PM
Cambridge Based Biotech, Phico Therapeutics, Announces Milestone in the Fight Against Multidrug Resistant Bacteria Enzyme NDM-1 9/12/2012 11:05:49 AM
Quotient BioResearch Announces Agreement with Phico Therapeutics and First Application of Rapidfact for Nasal Delivery 9/13/2011 11:57:46 AM
As Saspject Enters Phase II Phico Therapeutics Announces Dr Anthony F. Martin as Board Chairman 11/1/2010 2:16:04 PM
Wellcome Trust Award-Winning Company Phico Therapeutics Announces Success of Safety and Tolerability Trial 6/10/2010 2:26:24 PM
Wellcome Trust Award-Winning Company Phico Therapeutics Releases New SASPject PT1.2 Efficacy Data at ICCAC 9/15/2009 1:45:05 PM
Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust 1/28/2009 10:02:56 AM